Title: Big Data Analysis of Influenza Vaccination and Liver Cancer Risk in Hypertensive
Patients: Insights from a Nationwide Population-Based Cohort Study
Version: 4 Date: 18 Oct 2024
Reviewer's report:
Thank you for revising your study manuscript to the extent possible.
I understood that it takes you about 1.5 years from the time you apply to use the data to the
time you analyze the data. If so, could you not have applied for use of data until 2022, assuming
you had anticipated this and had applied for use 2 years earlier? I do not understand why you
used the 2001-2012 data. This study may be novel, but I do not think it is of much relevance to
current real-world clinical practice and society. Therefore, you would do well to apply for use
of the new data as soon as possible.
Title: Big Data Analysis of Influenza Vaccination and Liver Cancer Risk in Hypertensive
Patients: Insights from a Nationwide Population-Based Cohort Study
Version: 4 Date: 18 Oct 2024
Reviewer's report:
Thank you for revising your study manuscript to the extent possible.
I understood that it takes you about 1.5 years from the time you apply to use the data to the
time you analyze the data. If so, could you not have applied for use of data until 2022, assuming
you had anticipated this and had applied for use 2 years earlier? I do not understand why you
used the 2001-2012 data. This study may be novel, but I do not think it is of much relevance to
current real-world clinical practice and society. Therefore, you would do well to apply for use
of the new data as soon as possible.
Please review this paper.
user
Title: Big Data Analysis of Influenza Vaccination and Liver Cancer Risk in Hypertensive
Patients: Insights from a Nationwide Population-Based Cohort Study
Version: 4 Date: 18 Oct 2024
Reviewer's report:
Thank you for revising your study manuscript to the extent possible.
I understood that it takes you about 1.5 years from the time you apply to use the data to the
time you analyze the data. If so, could you not have applied for use of data until 2022, assuming
you had anticipated this and had applied for use 2 years earlier? I do not understand why you
used the 2001-2012 data. This study may be novel, but I do not think it is of much relevance to
current real-world clinical practice and society. Therefore, you would do well to apply for use
of the new data as soon as possible.
assistant